News Releases
Learn more about the latest news and happenings at Beckman Coulter.
Beckman Coulter Diagnostics, a clinical diagnostics leader, today introduces the new DxC 500i Clinical Analyzer*, an integrated clinical chemistry and immunoassay analyzer. As healthcare systems around the world strategically adopt networked laboratory operational models for better efficiency and patient access, Beckman Coulter continues to introduce new innovations to address the needs of the entire network with specific solutions for satellite or independent laboratories, as well as core laboratories.
Read moreBeckman Coulter, a global leader in clinical diagnostics, today announced U.S. Food and Drug Administration clearance of its Access NT-proBNP (N-terminal Pro B-type Natriuretic Peptide) assay for the assessment of heart failure in less than 11 minutes on the Beckman Coulter DxI 9000 Immunoassay Analyzer.
Read moreLearn more about the latest news and happenings at Beckman Coulter.
Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Read moreBiogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
Read moreBeckman Coulter’s DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.’s Annual Supplier Innovation Celebration
Read moreBeckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Read more